Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew Rowland

Showing results (171-180 of 184) with videos related to

Pageof 19
Sort By:
Journal of Clinical Epidemiology|January 14, 2024
Accessibility of clinical study reports supporting medicine approvals: a cross-sectional evaluationAshley M Hopkins, Natansh D Modi, Frank W Rockhold, et al.
JAMA Oncology|October 5, 2023
Heterogeneity and Utility of Pharmaceutical Company Sharing of Individual-Participant Data PackagesAshley M Hopkins, Natansh D Modi, Ahmad Y Abuhelwa, et al.
BMJ (Clinical Research Ed.)|March 20, 2024
Current safeguards, risk mitigation, and transparency measures of large language models against the generation of health disinformation: repeated cross sectional analysisBradley D Menz, Nicole M Kuderer, Stephen Bacchi, et al.
Frontiers in Public Health|May 26, 2025
Generative AI's healthcare professional role creep: a cross-sectional evaluation of publicly accessible, customised health-related GPTsBianca Chu, Natansh D Modi, Bradley D Menz, et al.
European Journal of Cancer (Oxford, England : 1990)|February 8, 2025
Generative AI chatbots for reliable cancer information: Evaluating web-search, multilingual, and reference capabilities of emerging large language modelsBradley D Menz, Natansh D Modi, Ahmad Y Abuhelwa, et al.
JMIR Infodemiology|April 20, 2026
Cross-Sectional Evaluation of Medical Disinformation Safeguards in Consumer-Facing Large Language Model PlatformsNatansh D Modi, Cyril A Alex, Abdulhalim A Awaty, et al.
Journal of the National Cancer Institute|February 16, 2026
Sex-based prognosis in industry-sponsored advanced solid tumour trials: an individual participant data meta-analysis of survival and adverse eventsRakchha Chhetri, Natansh D Modi, Bradley D Menz, et al.
BMC Medicine|October 23, 2023
A 10-year update to the principles for clinical trial data sharing by pharmaceutical companies: perspectives based on a decade of literature and policiesNatansh D Modi, Ganessan Kichenadasse, Tammy C Hoffmann, et al.
NPJ Digital Medicine|February 26, 2026
Vision-Enabled AI scribes reduce omissions in clinical conversations: evidence from simulated medication historiesBradley D Menz, Nicholas L Scarfo, Natansh D Modi, et al.
International Journal of Cancer|June 21, 2025
Patient-reported outcome thresholds and their associations with survival, adverse events, and quality of life in a pooled analysis of breast cancer trialsBradley D Menz, Natansh D Modi, Ahmad Y Abuhelwa, et al.
Pageof 19

Showing results (171-180 of 184) with videos related to

Sort By:
Pageof 19
Journal of Clinical Epidemiology|January 14, 2024
Accessibility of clinical study reports supporting medicine approvals: a cross-sectional evaluationAshley M Hopkins, Natansh D Modi, Frank W Rockhold, et al.
JAMA Oncology|October 5, 2023
Heterogeneity and Utility of Pharmaceutical Company Sharing of Individual-Participant Data PackagesAshley M Hopkins, Natansh D Modi, Ahmad Y Abuhelwa, et al.
BMJ (Clinical Research Ed.)|March 20, 2024
Current safeguards, risk mitigation, and transparency measures of large language models against the generation of health disinformation: repeated cross sectional analysisBradley D Menz, Nicole M Kuderer, Stephen Bacchi, et al.
Frontiers in Public Health|May 26, 2025
Generative AI's healthcare professional role creep: a cross-sectional evaluation of publicly accessible, customised health-related GPTsBianca Chu, Natansh D Modi, Bradley D Menz, et al.
European Journal of Cancer (Oxford, England : 1990)|February 8, 2025
Generative AI chatbots for reliable cancer information: Evaluating web-search, multilingual, and reference capabilities of emerging large language modelsBradley D Menz, Natansh D Modi, Ahmad Y Abuhelwa, et al.
JMIR Infodemiology|April 20, 2026
Cross-Sectional Evaluation of Medical Disinformation Safeguards in Consumer-Facing Large Language Model PlatformsNatansh D Modi, Cyril A Alex, Abdulhalim A Awaty, et al.
Journal of the National Cancer Institute|February 16, 2026
Sex-based prognosis in industry-sponsored advanced solid tumour trials: an individual participant data meta-analysis of survival and adverse eventsRakchha Chhetri, Natansh D Modi, Bradley D Menz, et al.
BMC Medicine|October 23, 2023
A 10-year update to the principles for clinical trial data sharing by pharmaceutical companies: perspectives based on a decade of literature and policiesNatansh D Modi, Ganessan Kichenadasse, Tammy C Hoffmann, et al.
NPJ Digital Medicine|February 26, 2026
Vision-Enabled AI scribes reduce omissions in clinical conversations: evidence from simulated medication historiesBradley D Menz, Nicholas L Scarfo, Natansh D Modi, et al.
International Journal of Cancer|June 21, 2025
Patient-reported outcome thresholds and their associations with survival, adverse events, and quality of life in a pooled analysis of breast cancer trialsBradley D Menz, Natansh D Modi, Ahmad Y Abuhelwa, et al.
Pageof 19